Literature DB >> 23180887

Best practices for purification and characterization of PAMAM dendrimer.

Douglas G Mullen1, Ankur Desai, Mallory A van Dongen, Mark Barash, James R Baker, Mark M Banaszak Holl.   

Abstract

Poly(amidoamine) (PAMAM) dendrimer are branched polymers with low degrees of heterogeneity. Current synthesis methods, however, result in substantial batch variability. We present our optimized procedure for post-synthesis (and post-market) purification of a generation 5 PAMAM dendrimer by membrane dialysis and demonstrate its effectiveness and limitations using a representative lot of biomedical grade dendrimer. This method successfully removes trailing generation defect structures, thereby reducing the heterogeneity of the material (PDI reduced from 1.04 to 1.02). Optimized analytical techniques to characterize the unpurified and purified dendrimer are also detailed. The efficiency of the purification method is successfully monitored by these analytics and dendrimer parameters that are critical for subsequent modification reactions and biological evaluation (M(n), M(w), PDI, average number of end groups) obtained. To provide better definition of the variability that should be expected between lots of synthesized material, HPLC traces for three additional commercial lots of dendrimer are also presented.

Entities:  

Year:  2012        PMID: 23180887      PMCID: PMC3501731          DOI: 10.1021/ma300485p

Source DB:  PubMed          Journal:  Macromolecules        ISSN: 0024-9297            Impact factor:   5.985


  23 in total

Review 1.  Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine.

Authors:  Didier Astruc; Elodie Boisselier; Cátia Ornelas
Journal:  Chem Rev       Date:  2010-04-14       Impact factor: 60.622

2.  The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

Authors:  Seungpyo Hong; Pascale R Leroueil; István J Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Chem Biol       Date:  2007-01

3.  The mechanism of polyplex internalization into cells: testing the GM1/caveolin-1 lipid raft mediated endocytosis pathway.

Authors:  Rong Qi; Douglas G Mullen; James R Baker; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

4.  HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein.

Authors:  Xiangyang Shi; Xiangdong Bi; T Rose Ganser; Seungpyo Hong; Lukasz A Myc; Ankur Desai; Mark M Banaszak Holl; James R Baker
Journal:  Analyst       Date:  2006-06-08       Impact factor: 4.616

5.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Authors:  Jolanta F Kukowska-Latallo; Kimberly A Candido; Zhengyi Cao; Shraddha S Nigavekar; Istvan J Majoros; Thommey P Thomas; Lajos P Balogh; Mohamed K Khan; James R Baker
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

6.  Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability.

Authors:  Seungpyo Hong; Pascale R Leroueil; Elizabeth K Janus; Jennifer L Peters; Mary-Margaret Kober; Mohammad T Islam; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

7.  Targeting and inhibition of cell growth by an engineered dendritic nanodevice.

Authors:  Thommey P Thomas; Istvan J Majoros; Alina Kotlyar; Jolanta F Kukowska-Latallo; Anna Bielinska; Andrzej Myc; James R Baker
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

8.  A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.

Authors:  Douglas G Mullen; Ming Fang; Ankur Desai; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

Review 9.  The role of macromolecular architecture in passively targeted polymeric carriers for drug and gene delivery.

Authors:  Scott M Grayson; W T Godbey
Journal:  J Drug Target       Date:  2008-06       Impact factor: 5.121

10.  PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

Authors:  István J Majoros; Andrzej Myc; Thommey Thomas; Chandan B Mehta; James R Baker
Journal:  Biomacromolecules       Date:  2006-02       Impact factor: 6.988

View more
  17 in total

1.  Preparation and long-term biodistribution studies of a PAMAM dendrimer G5-Gd-BnDOTA conjugate for lymphatic imaging.

Authors:  Ana Christina Opina; Karen J Wong; Gary L Griffiths; Baris I Turkbey; Marcelino Bernardo; Takahito Nakajima; Hisataka Kobayashi; Peter L Choyke; Olga Vasalatiy
Journal:  Nanomedicine (Lond)       Date:  2014-11-13       Impact factor: 5.307

Review 2.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

3.  Quantitative analysis of generation and branch defects in G5 poly(amidoamine) dendrimer.

Authors:  Mallory A van Dongen; Ankur Desai; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Polymer (Guildf)       Date:  2013-07-19       Impact factor: 4.430

4.  Increase in Dye:Dendrimer Ratio Decreases Cellular Uptake of Neutral Dendrimers in RAW Cells.

Authors:  Sriram Vaidyanathan; Milan Kaushik; Casey Dougherty; Rahul Rattan; Sascha N Goonewardena; Mark M Banaszak Holl; Janet Monano; Stassi DiMaggio
Journal:  ACS Biomater Sci Eng       Date:  2016-07-18

5.  PAMAM Dendrimers as Quantized Building Blocks for Novel Nanostructures.

Authors:  Mallory A van Dongen; S Vaidyanathan; Mark M Banaszak Holl
Journal:  Soft Matter       Date:  2013-12-21       Impact factor: 3.679

6.  Quantitative Measurement of Cationic Polymer Vector and Polymer-pDNA Polyplex Intercalation into the Cell Plasma Membrane.

Authors:  Sriram Vaidyanathan; Kevin B Anderson; Rachel L Merzel; Binyamin Jacobovitz; Milan P Kaushik; Christina N Kelly; Mallory A van Dongen; Casey A Dougherty; Bradford G Orr; Mark M Banaszak Holl
Journal:  ACS Nano       Date:  2015-05-14       Impact factor: 15.881

7.  Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis.

Authors:  Brett C Geiger; Sheryl Wang; Robert F Padera; Alan J Grodzinsky; Paula T Hammond
Journal:  Sci Transl Med       Date:  2018-11-28       Impact factor: 17.956

8.  Rapid Exchange Between Free and Bound States in RNA-Dendrimer Polyplexes: Implications on the Mechanism of Delivery and Release.

Authors:  Anisha Shakya; Casey A Dougherty; Yi Xue; Hashim M Al-Hashimi; Mark M Banaszak Holl
Journal:  Biomacromolecules       Date:  2015-12-11       Impact factor: 6.988

9.  Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.

Authors:  Erika N Cline; Ming-Hsin Li; Seok Ki Choi; Jeffrey F Herbstman; Neha Kaul; Edgar Meyhöfer; Georgios Skiniotis; James R Baker; Ronald G Larson; Nils G Walter
Journal:  Biomacromolecules       Date:  2013-02-21       Impact factor: 6.988

10.  Generation 3 PAMAM dendrimer TAMRA conjugates containing precise dye/dendrimer ratios.

Authors:  Janet Manono; Casey A Dougherty; Kirsten Jones; Joshua DeMuth; Mark M Banaszak Holl; Stassi DiMaggio
Journal:  Mater Today (Kidlington)       Date:  2015-06-09       Impact factor: 31.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.